V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220013520 | 220014350 | 0 | 78.6 | Palliative (P) | 2016-06-10 | 2016-12-26 | Dasatinib | 2 | N | 220030353 | DASATINIB |
| 220013521 | 220014350 | 1.8 | 72.6 | null | 2013-11-28 | 2013-12-06 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | null | 220030353 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013522 | 220007931 | 0 | 81 | Disease modification (D) | 2014-10-22 | 2014-10-23 | Dasatinib | N | N | 220030362 | DASATINIB |
| 220013523 | 220007931 | null | null | Curative (C) | 2017-02-11 | 2017-03-24 | Dasatinib | 02 | N | 220030362 | DASATINIB |
| 220013524 | 220007932 | 1.49 | 82.6 | Disease modification (D) | 2014-12-21 | 2015-01-09 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 220030366 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013525 | 220007934 | null | 55.3 | Disease modification (D) | 2014-02-16 | 2014-02-18 | Dasatinib | N | null | 220030367 | DASATINIB |
| 220013526 | 220007935 | 1.6 | 79 | null | 2014-07-16 | 2014-07-26 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 220030379 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013527 | 220007936 | 1.69 | 60.8 | Disease modification (D) | null | 2014-11-25 | AML 18 TRIAL | 01 | N | 220030379 | AML18 TRIAL |
| 220013528 | 220007938 | null | 95.1 | Curative (C) | 2015-06-23 | 2015-06-26 | Alemtuz+Fludara+Melphalan RIC MUD | null | N | 220030389 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013529 | 220007939 | 1.58 | 75 | Disease modification (D) | 2014-04-28 | 2014-04-29 | Rituximab (Maintenance) | 02 | N | 220030395 | RITUXIMAB |
| 220013530 | 220014353 | 0 | 76 | Curative (C) | 2014-05-27 | 2014-08-05 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 02 | N | 220030395 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013531 | 220014353 | 0 | 78.8 | Disease modification (D) | 2014-03-16 | 2014-03-16 | Rituximab | N | N | 220030395 | RITUXIMAB |
| 220013532 | 220007940 | null | null | Palliative (P) | 2016-11-01 | 2017-04-09 | Dasatinib | N | N | 220030400 | DASATINIB |
| 220013533 | 220007940 | 1.9 | 56.2 | Curative (C) | 2015-12-18 | 2015-12-25 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220030400 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013534 | 220007940 | 0 | 42.5 | Curative (C) | 2017-04-06 | 2017-05-28 | AML 18 TRIAL | N | N | 220030400 | AML18 TRIAL |
| 220013539 | 220020911 | null | 56.7 | Curative (C) | 2015-10-15 | 2015-10-15 | AML 18 TRIAL | N | N | 220030426 | AML18 TRIAL |
| 220013540 | 220007942 | null | 42.5 | Palliative (P) | 2013-09-14 | 2014-01-21 | AML 18 TRIAL | 1 | N | 220030429 | AML18 TRIAL |
| 220013541 | 220007943 | 0 | 58.7 | Curative (C) | 2016-08-30 | 2016-09-10 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220030431 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013542 | 220014358 | 0 | 80.3 | Curative (C) | 2017-04-21 | 2017-07-13 | Rituximab | N | null | 220030435 | RITUXIMAB |
| 220013543 | 220007950 | 1.63 | null | Curative (C) | 2013-08-03 | 2013-08-08 | Dasatinib | N | N | 220030438 | DASATINIB |
| 220013544 | 220007952 | 1.76 | 66.2 | Curative (C) | 2013-05-20 | 2013-05-22 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | null | 220030440 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013545 | 220007953 | null | 0 | Palliative (P) | 2014-01-17 | 2014-01-19 | Dasatinib | 2 | N | 220030444 | DASATINIB |
| 220013546 | 220007953 | 1.82 | 56.6 | Curative (C) | 2014-12-15 | 2014-12-15 | AML18 PILOT TRIAL | null | N | 220030444 | PILOT TRIAL |
| 220013547 | 220007954 | 1.79 | null | Adjuvant (A) | 2015-08-03 | 2015-11-07 | Dasatinib | N | N | 220030445 | DASATINIB |
| 220013548 | 220007954 | null | null | Curative (C) | 2015-12-27 | 2015-12-27 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | 220030445 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013549 | 220007954 | 0 | 83.3 | null | 2016-07-29 | 2016-09-14 | AML18 PILOT TRIAL | N | null | 220030445 | PILOT TRIAL |
| 220013550 | 220007954 | 1.66 | null | null | 2018-10-22 | 2018-10-22 | Dasatinib | null | null | 220030445 | DASATINIB |
| 220013551 | 220007954 | 0 | 65.2 | Disease modification (D) | 2015-03-15 | 2017-04-01 | Dasatinib | N | N | 220030445 | DASATINIB |
| 220013552 | 220007955 | 1.84 | 70.6 | Curative (C) | null | 2016-11-01 | AML 18 TRIAL | Y | null | 220030458 | AML18 TRIAL |
| 220013553 | 220007956 | null | 56.6 | Curative (C) | 2016-03-05 | 2016-06-26 | Alemtuz+Fludara+Melphalan RIC MUD | 2 | N | 220030458 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013554 | 220007957 | 1.84 | 65.2 | Disease modification (D) | 2014-05-17 | 2015-10-01 | Dasatinib | N | N | 220030460 | DASATINIB |
| 220013555 | 220014365 | 0 | null | Curative (C) | 2017-06-11 | 2017-06-12 | Dasatinib | N | N | 220030464 | DASATINIB |
| 220013556 | 220007959 | null | 63.4 | Disease modification (D) | null | 2013-09-27 | AML 18 TRIAL | 01 | N | 220030466 | AML18 TRIAL |
| 220013557 | 220007959 | null | 72.9 | Curative (C) | 2013-08-22 | 2013-10-10 | AML 18 TRIAL | 1 | N | 220030466 | AML18 TRIAL |
| 220013558 | 220017838 | 1.8 | 73 | null | 2014-12-25 | 2014-12-25 | AML18 PILOT TRIAL | null | null | 220030471 | PILOT TRIAL |
| 220013559 | 220017838 | 0 | 42.5 | Disease modification (D) | 2017-11-28 | 2017-11-29 | AML 18 TRIAL | 1 | Y | 220030471 | AML18 TRIAL |
| 220013560 | 220007967 | 1.63 | 0 | Disease modification (D) | 2014-11-22 | 2017-06-27 | Dasatinib | 02 | N | 220030478 | DASATINIB |
| 220013561 | 220020916 | null | null | Curative (C) | 2013-06-09 | 2013-09-20 | Rituximab | N | N | 220030478 | RITUXIMAB |
| 220013562 | 220014375 | 0 | null | Curative (C) | null | 2013-10-14 | Rituximab | N | N | 220030493 | RITUXIMAB |
| 220013563 | 220007975 | 0 | 96 | Disease modification (D) | 2018-01-25 | 2018-03-11 | AML18 PILOT TRIAL | 01 | N | 220030494 | PILOT TRIAL |
| 220013564 | 220007977 | 1.9 | 108 | Disease modification (D) | 2014-07-22 | 2014-07-22 | AML 18 TRIAL | Y | null | 220030495 | AML18 TRIAL |
| 220013565 | 220007981 | null | 65.6 | null | 2013-11-23 | 2014-01-09 | AML18 PILOT TRIAL | N | N | 220030497 | PILOT TRIAL |
| 220013566 | 220007984 | null | 47.8 | Curative (C) | null | 2014-03-28 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220030497 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013567 | 220021543 | null | 103.8 | Curative (C) | 2013-05-15 | 2013-05-22 | Alemtuz+Fludara+Melphalan RIC MUD | 2 | N | 220030506 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013568 | 220007985 | null | 94.2 | Disease modification (D) | 2015-11-06 | 2015-11-06 | Rituximab | N | null | 220030508 | RITUXIMAB |
| 220013571 | 220007986 | 1.63 | 102 | Curative (C) | 2016-10-07 | 2016-10-07 | AML 18 TRIAL | N | N | 220030515 | AML18 TRIAL |
| 220013572 | 220007988 | 1.8 | 73 | Curative (C) | 2013-07-25 | 2013-08-21 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220030520 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013573 | 220007990 | 1.62 | 138 | Disease modification (D) | 2015-03-23 | 2015-03-30 | Dasatinib | N | N | 220030523 | DASATINIB |
| 220013574 | 220007991 | 1.88 | 121.1 | Curative (C) | 2013-04-14 | 2013-04-15 | Alemtuz+Fludara+Melphalan RIC MUD | 2 | N | 220030524 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013575 | 220007994 | 1.75 | 89 | Disease modification (D) | 2014-09-03 | 2014-12-25 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 220030530 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |